510(k) device
Sparc System and Monarc, Monarc, and Monarc C Systems
American Medical Systems · Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (OTN, Class II) · First FDA decision Sep 17, 2008, newest Dec 5, 2013Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
8
Naming "Sparc"
MAUDE reports
162
Brand "Sparc", since 2015
PubMed studies
3,436
Mentioning "Sparc"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sparc System and Monarc, Monarc, and Monarc C Systems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K131229 · Decided Dec 5, 2013 · 219 days after receipt
Device type: Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (OTN) · General & Plastic Surgery
K081613 · Decided Sep 17, 2008 · 100 days after receipt
Device type: Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (OTN) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sacral Nerve Stimulation for Urge Urinary IncontinenceNational analysisReview closedCAG-00058NUpdated Sep 15, 2026
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Home Biofeedback For Urinary IncontinenceNational analysisReview closedCAG-00118NUpdated Sep 14, 2026
- Biofeedback for Urinary IncontinenceNational analysisReview closedCAG-00020NUpdated Sep 14, 2026
- Sacral Nerve Stimulation For Urinary IncontinenceNational determinationOn the books230.18Updated Dec 8, 2025
- Biofeedback Therapy for the Treatment of Urinary IncontinenceNational determinationOn the books30.1.1Updated Sep 24, 2015
- Sacral Nerve Stimulation for the Treatment of Urinary and Fecal IncontinenceLocal determinationIn effectL39543Palmetto GBAUpdated Sep 12, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Sparc", any status and sponsor, newest update first.
Mclean HospitalAcademic, hospital or other
NCT07785102 · 30 participants (planned) · Start Oct 1, 2026 · Primary completion Dec 31, 2026
Device: TMS · For: Major Depression
Sites: Belmont, Massachusetts
- An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant RecipientsActive, not recruiting
CochlearNot on our public-company list
NCT06867380 · 120 participants (planned) · Start May 27, 2025 · Primary completion Apr 2030
Device: Investigational sound coding strategy A; Cochlear default sound coding strategy A and 2 more · For: Cochlear Implant Recipients; Hearing Loss, Cochlear
Sites: Carlton, Australia; East Melbourne, Australia
- A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS TrialPivotal-lookingRecruiting
NeuroRx, Inc.Not on our public-company list
NCT07227103 · 240 participants (planned) · Start Dec 1, 2026 · Primary completion Dec 31, 2027
Device: Neuronavigated robotic-enabled TMS; Sham TMS · For: Treatment Resistant Depression; Treatment Resistant Depression (TRD)
Sites: Sarasota, Florida; West Palm Beach, Florida; Belmont, Massachusetts
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sparc", and for the whole product code for context.
This brand
162 reports: 3 malfunction, 44 injury, 114 death
Whole product code OTN
16,635 reports: 480 malfunction, 15,827 injury, 316 death
Newest reports for this brand
- SPARC SLINGInjury
MW5102034 · Received Jun 22, 2021 · Event dated May 13, 2021
Device type: Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (OTN)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Emotional Changes; Unspecified Infection; Neuropathy; Ambulation or Postural Difficulties; Fecal Incontinence; Urinary Incontinence
- SPARCInjury
JOHNSON AND JOHNSON / ETHICON, INC
MW5100331 · Received Mar 26, 2021 · Event dated Jan 1, 2019
Device type: Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (OTN)
Device problem as coded: Material Erosion
Patient problem as coded: Pain; Numbness; Device Embedded In Tissue or Plaque
- PROLENE MESHInjury
MW5086657 · Received May 14, 2019 · 2 other devices named on this report
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abdominal Pain; Autoimmune Disorder; Unspecified Infection; Patient Problem/Medical Problem; No Code Available
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
American Medical Systems, Inc.
Z-0805-2015 · Started Oct 15, 2014 · Posted by FDA Dec 16, 2014
Reason given: During routine periodic packaging testing, AMS identified that in simulated extreme shipping and handling situations the sterile barrier packaging of the Needle Passer components supplied with the AdVance" Male Sling System; Model # 720088-01; AdVance" XP Male Sling System; Model # 720163-01; Monarc" C Subfacial...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (OTN)
Published research
The most relevant PubMed records for "Sparc"[tiab]. The summary above synthesizes these.
- The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging.
Ryu S, Sidorov S, Ravussin E, et al. · Immunity · 2022Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- SPARC/osteonectin in mineralized tissue.
Rosset EM, Bradshaw AD · Matrix Biol · 2016Review, Research Support, U.S. Gov't, Non-P.H.S.
- Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity.
Ryu S, Spadaro O, Sidorov S, et al. · J Clin Invest · 2023Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation.
Du J, Qian T, Lu Y, et al. · Exp Cell Res · 2023Research Support, Non-U.S. Gov't
- Skip the buffet, for SPARC's sake.
Zhai L, Krawczyk CM · Immunity · 2022Comment
- Purification of SPARC/osteonectin.
Sage EH · Curr Protoc Cell Biol · 2003
- The association of SPARC with hypertension and its function in endothelial-dependent relaxation.
Li X, Zhao W, Li X, et al. · Atherosclerosis · 2024Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- SPARC functions as an inhibitor of adipogenesis.
Nie J, Sage EH · J Cell Commun Signal · 2009
- The role of SPARC in extracellular matrix assembly.
Bradshaw AD · J Cell Commun Signal · 2009
- Osteonectin (SPARC) prognostic value in prostate cancer.
Chekhun V, Borikun T, Zadvornyi T, et al. · Pathol Res Pract · 2024
- SPARC: a potential target for functional nanomaterials and drugs.
Jiang S, Sun HF, Li S, et al. · Front Mol Biosci · 2023Review
- Pre-eclampsia onset and SPARC: A possible involvement in placenta development.
Tossetta G, Fantone S, Giannubilo SR, et al. · J Cell Physiol · 2019Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OTN.
- Desara Mesh, Desara BlueCaldera Medical, Inc. · 510(k) 2013
- Advantage Ultra System, Advantage Fit Ultra System, Lynx Ultra SystemBoston Scientific Corporation · 510(k) 2023
- Gynecare Tvt Exact Continence SystemETHICON, Inc. · 510(k) 2013
- Bioarc Sp Sling Kit and Bioarc to Sling Kit, Models 72403851, 72403996American Medical Systems, Inc. · 510(k) 2004
- Modification to Sparc Sling SystemAmerican Medical Systems, Inc. · 510(k) 2002
- Sparc Sling SystemAmerican Medical Systems, Inc. · 510(k) 2001
- Kim BlueDesarrollo e Investigación Médica Aragonesa S.L. · 510(k) 2026
- ArcSP Suprapubic Sling SystemUrocure, LLC · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.